Inactive Instrument

Calendar Sarepta Therapeutics Inc Nasdaq

Equities

US0023461041

End-of-day quote Nasdaq
- USD 0.00% Intraday chart for Sarepta Therapeutics Inc

Chart calendar Sarepta Therapeutics Inc

4bad63e3048772185d80a9402493a90.XnNTaA4FZ-x-6XCdryTmQZpRuf0QOoeB4aauyNyxoCk.DhwpEkl_MJYEowfXxla5c9MO-75YXdPP0_7ArIPSz1MPGTdFV1MqmTexJQ~60a617aca54310df602e06d00c48a085

Upcoming events on Sarepta Therapeutics Inc

2024-04-30 Q1 2024 Earnings Release (Projected)
2024-07-30 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)

Past events on Sarepta Therapeutics Inc

2024-03-12 03:05 pm Barclays Global Healthcare Conference
2024-03-11 10:00 am Leerink Partners Global Biopharma Conference
2024-02-28 04:30 pm Q4 2023 Earnings Call
2024-02-28 04:05 pm Q4 2023 Earnings Release
2024-01-29 08:30 am SRP-5051-201 Phase 2 Part B Study Results Call
2024-01-29 08:30 am SRP-5051-201 Phase 2 Part B Study Results Call
2024-01-08 12:00 pm JPMorgan Healthcare Conference
2023-11-09 09:00 am UBS BioPharma Conference
2023-11-01 04:30 pm Q3 2023 Earnings Call
2023-11-01 04:05 pm Q3 2023 Earnings Release
2023-10-30 04:30 pm Business Update Call
2023-09-11 08:40 am Morgan Stanley Global Healthcare Conference
2023-08-02 04:30 pm Q2 2023 Earnings Call
2023-08-02 04:05 pm Q2 2023 Earnings Release
2023-07-10 11:00 am Cowen RNA Therapeutics Summit
2023-06-22 04:30 pm ELEVIDYS FDA Approval Call
2023-06-08 10:00 am Annual General Meeting
2023-05-02 04:30 pm Q1 2023 Earnings Call
2023-05-02 04:05 pm Q1 2023 Earnings Release
2023-03-16 04:30 pm SRP-9001 BLA Update Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
381
379
0.54%
540
537
0.61%
702
689
1.8%
933
925
0.86%
1 243
1 233
0.87%

1 821

EBITDA
Million USD
Released
Forecast
Spread
-681
-596
-14.33%
-537
-535
-0.4%
-422
-479
11.97%
-494
-518
4.49%
0,00
-278
-

193

EBIT
Million USD
Released
Forecast
Spread
-706
-611
-15.49%
-564
-518
-8.89%
-460
-460
-0.03%
-536
-517
-3.66%
-268
-303
11.68%

202

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-714
-618
-15.52%
-553
-522
-6%
-419
-433
3.28%
-690
-708
2.57%
-520
-559
6.94%

207

Net income
Million USD
Released
Forecast
Spread
-715
-617
-15.85%
-554
-519
-6.72%
-419
-438
4.35%
-703
-677
-3.95%
-536
-579
7.41%

222

EPS
USD
Released
Forecast
Spread
-9,71
-8,44
-15.05%
-7,11
-6,66
-6.71%
-5,15
-5,20
0.98%
-8,03
-7,54
-6.49%
-5,80
-6,39
9.19%

2,52

Announcement Date26/02/2001/03/2101/03/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
201
198
1.53%
211
208
1.24%
233
221
5.56%
230
235
-1.83%
258
251
3.16%
254
241
4.98%
261
262
-0.36%
332
287
15.71%
397
386
2.75%

375


392


494


576


749

EBIT
Million USD
Released
Forecast
Spread
-106
-99,6
-6.2%
-86,9
-109
20.02%
-211
-92,7
-127.71%
-131
-112
-17.53%
-107
-105
-1.92%
-138
-116
-19.22%
-134
-169
21.04%
-20,8
-120
82.64%
24,6
-7,43
431.59%

-18,4


-17,5


79,4


146


283

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-122
-106
-15.45%
-104
-115
9.58%
-228
-99,6
-128.92%
-256
-132
-93.89%
-101
-115
11.92%
-513
-129
-298.57%
-14,6
-156
90.67%
-33,2
-105
68.47%
40,4
4,23
854.54%

-9,95


-7,90


83,7


148


286

Net income
Million USD
Released
Forecast
Spread
-122
-114
-6.91%
-105
-118
10.76%
-231
-101
-129.34%
-258
-122
-111.7%
-109
-103
-6.06%
-517
-116
-343.89%
-23,9
-164
85.42%
-40,9
-115
64.4%
45,7
-5,49
931.45%

-4,23


2,64


86,8


144


283

EPS
USD
Released
Forecast
Spread
-1,42
-1,22
-16.65%
-1,20
-1,35
11.25%
-2,65
-1,15
-130.76%
-2,94
-1,41
-109.25%
-1,24
-1,18
-5.21%
-5,86
-1,29
-353.43%
-0,27
-1,80
85.01%
-0,46
-1,26
63.38%
0,47
-0,05
1083.47%

0,00


0,01


0,82


1,52


3,76

Announcement Date01/03/2204/05/2202/08/2202/11/2228/02/2302/05/2302/08/2301/11/2328/02/24-----